Ironwood Pharmaceuticals
(NASDAQ) IRWD
Ironwood Pharmaceuticals Financials at a Glance
Market Cap
$592.61M
Revenue (TTM)
$361.51M
Net Income (TTM)
$102.18M
EPS (TTM)
$0.60
P/E Ratio
6.03
Dividend
$0.00
Beta (Volatility)
0.68 (Low)
Dividend
$0.00
Beta (Volatility)
0.68 (Low)
Price
$3.58
Volume
2,034,721
Open
$3.63
Price
$3.58
Volume
2,034,721
Open
$3.63
Previous Close
$3.57
Daily Range
$3.50 - $3.67
52-Week Range
$0.56 - $5.78
Dividend
$0.00
Beta (Volatility)
0.68 (Low)
Price
$3.58
Volume
2,034,721
Open
$3.63
Previous Close
$3.57
Daily Range
$3.50 - $3.67
52-Week Range
$0.56 - $5.78
IRWD News
3 Great Stocks Under $10
IRWD: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Ironwood Pharmaceuticals
Industry
Biotechnology
Sector
Health CareEmployees
100
CEO
Thomas A. McCourt
Website
www.ironwoodpharma.comHeadquarters
Boston, MA 02110, US
IRWD Financials
Key Financial Metrics (TTM)
Gross Margin
100%
Operating Margin
56%
Net Income Margin
28%
Return on Equity
0%
Return on Capital
1%
Return on Assets
24%
Earnings Yield
16.58%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$592.61M
Shares Outstanding
164.61M
Volume
2.03M
Avg. Volume
2.54M
Financials (TTM)
Gross Profit
$296.15M
Operating Income
$118.76M
EBITDA
$104.65M
Operating Cash Flow
$127.04M
Capital Expenditure
-$34.00K
Free Cash Flow
$127.01M
Cash & ST Invst.
$215.46M
Total Debt
$597.80M
Ironwood Pharmaceuticals Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$106.51M
+158.9%
Gross Profit
$106.06M
+673.6%
Gross Margin
99.58%
N/A
Market Cap
$592.61M
N/A
Market Cap/Employee
$2.34M
N/A
Employees
253
N/A
Net Income
$40.77M
+209.1%
EBITDA
$72.98M
+824.7%
Quarterly Fundamentals
Net Cash
-$376.89M
+23.2%
Accounts Receivable
$105.84M
+166.1%
Inventory
$0.00
N/A
Long Term Debt
$394.23M
-33.8%
Short Term Debt
$203.12M
+6239.7%
Return on Assets
23.51%
N/A
Return on Invested Capital
1.02%
N/A
Free Cash Flow
$5.12M
-74.3%
Operating Cash Flow
$5.12M
-74.3%